Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chlamydia pneumoniae and atherosclerosis].

A Fortini1, G Corti, C Cappelletti

  • 1Nuovo Ospedale San Giovanni di Dio di Firenze.

Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|January 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

AFM Force Volume for Extracellular Vesicle Detection and Membrane Blebbing Analysis Through Mechanical Signature Mapping.

Journal of molecular recognition : JMR·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026

Chlamydia pneumoniae infection is linked to a higher risk of atherosclerosis. While the association is clear, its causal role and the effectiveness of antibiotic treatment require further large-scale clinical trials.

Area of Science:

  • Infectious Diseases
  • Cardiovascular Medicine
  • Microbiology

Context:

  • Atherosclerosis is recognized as an inflammatory disease.
  • The role of infectious agents, particularly Chlamydia pneumoniae, is increasingly investigated.
  • Numerous studies suggest a correlation between Chlamydia pneumoniae infection and atherosclerosis.

Purpose:

  • To critically review and analyze existing literature on the association between Chlamydia pneumoniae and atherosclerosis.
  • To evaluate the potential of Chlamydia pneumoniae as a causative agent in atherosclerosis.
  • To assess the implications for atherosclerosis as an infectious disease treatable with antimicrobial therapy.

Summary:

  • Over twenty sero-epidemiological studies indicate a doubled risk of cardiovascular events in individuals with Chlamydia pneumoniae infection.

Related Experiment Videos

  • Chlamydia pneumoniae has been detected in a significant percentage of atherosclerotic plaques but rarely in healthy arterial tissue.
  • Experimental data suggest Chlamydia pneumoniae's biological properties could contribute to plaque development.

    • Impact:

    • The causal role of Chlamydia pneumoniae in atherosclerosis remains uncertain, necessitating further research.
    • The efficacy of antimicrobial therapy for preventing or slowing atherosclerosis progression requires confirmation in larger human trials.
    • Ongoing large-scale clinical trials aim to clarify the role of antibiotics in the secondary prevention of atherosclerotic diseases.